Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F van de Werf

Showing results (181-190 of 290) with videos related to

Pageof 29
Sort By:
The Journal of the Acoustical Society of America|August 27, 1999
Nonlinear propagation effects on broadband attenuation measurements and its implications for ultrasonic tissue characterizationJ D'hooge, B Bijnens, J Nuyts, et al.
Circulation|October 12, 2000
Polyethylene glycol-derivatized cysteine-substitution variants of recombinant staphylokinase for single-bolus treatment of acute myocardial infarctionD Collen, P Sinnaeve, E Demarsin, et al.
Nuklearmedizin. Nuclear Medicine|June 1, 1993
Early and late effects of rt-PA vs placebo on left ventricular function measured by nuclear ventriculographyL Mortelmans, I Scheys, T Brzostek, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|May 23, 2001
Circulating oxidized LDL is a useful marker for identifying patients with coronary artery diseaseP Holvoet, A Mertens, P Verhamme, et al.
Herz|November 5, 1999
Resolution of ST-segment elevation in acute myocardial infarction--early prognostic significance after thrombolytic therapy. Results from the COBALT trialJ Carlsson, U Kamp, D Härtel, et al.
Circulation|March 18, 1997
Experimental study of thrombogenicity and foreign body reaction induced by heparin-coated coronary stentsI De Scheerder, K Wang, K Wilczek, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|July 1, 1996
Assessment of the optimal atrioventricular delay in dual chamber-paced patients by a portable scintillation probe (VEST)L Mortelmans, W Vanhecke, D Mertens, et al.
Coronary Artery Disease|March 1, 1995
Comparison of a low-molecular-weight heparin (nadroparin calcium) and unfractionated heparin as adjunct to coronary thrombolysis with alteplase and aspirin in dogsL Jun, J Arnout, P Vanhove, et al.
Journal of the American College of Cardiology|July 1, 1986
Coronary thrombolysis by intravenous infusion of recombinant single chain urokinase-type plasminogen activator or recombinant urokinase in baboons: effect on regional blood flow, infarct size and hemostasisW Flameng, J Vanhaecke, D C Stump, et al.
Journal of Clinical Pharmacology|May 12, 2000
Pharmacokinetics and pharmacodynamics of tenecteplase: results from a phase II study in patients with acute myocardial infarctionN B Modi, N L Fox, F W Clow, et al.
Pageof 29

Showing results (181-190 of 290) with videos related to

Sort By:
Pageof 29
The Journal of the Acoustical Society of America|August 27, 1999
Nonlinear propagation effects on broadband attenuation measurements and its implications for ultrasonic tissue characterizationJ D'hooge, B Bijnens, J Nuyts, et al.
Circulation|October 12, 2000
Polyethylene glycol-derivatized cysteine-substitution variants of recombinant staphylokinase for single-bolus treatment of acute myocardial infarctionD Collen, P Sinnaeve, E Demarsin, et al.
Nuklearmedizin. Nuclear Medicine|June 1, 1993
Early and late effects of rt-PA vs placebo on left ventricular function measured by nuclear ventriculographyL Mortelmans, I Scheys, T Brzostek, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|May 23, 2001
Circulating oxidized LDL is a useful marker for identifying patients with coronary artery diseaseP Holvoet, A Mertens, P Verhamme, et al.
Herz|November 5, 1999
Resolution of ST-segment elevation in acute myocardial infarction--early prognostic significance after thrombolytic therapy. Results from the COBALT trialJ Carlsson, U Kamp, D Härtel, et al.
Circulation|March 18, 1997
Experimental study of thrombogenicity and foreign body reaction induced by heparin-coated coronary stentsI De Scheerder, K Wang, K Wilczek, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|July 1, 1996
Assessment of the optimal atrioventricular delay in dual chamber-paced patients by a portable scintillation probe (VEST)L Mortelmans, W Vanhecke, D Mertens, et al.
Coronary Artery Disease|March 1, 1995
Comparison of a low-molecular-weight heparin (nadroparin calcium) and unfractionated heparin as adjunct to coronary thrombolysis with alteplase and aspirin in dogsL Jun, J Arnout, P Vanhove, et al.
Journal of the American College of Cardiology|July 1, 1986
Coronary thrombolysis by intravenous infusion of recombinant single chain urokinase-type plasminogen activator or recombinant urokinase in baboons: effect on regional blood flow, infarct size and hemostasisW Flameng, J Vanhaecke, D C Stump, et al.
Journal of Clinical Pharmacology|May 12, 2000
Pharmacokinetics and pharmacodynamics of tenecteplase: results from a phase II study in patients with acute myocardial infarctionN B Modi, N L Fox, F W Clow, et al.
Pageof 29